A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 331



Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
Times Cited: 128




List of shared articles



Times cited

Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing program.
Melanie Care, Jeanna McCuaig, Blaise Clarke, Sylvie Grenier, Raymond H Kim, Marjan Rouzbahman, Natalie Stickle, Marcus Bernardini, Tracy L Stockley. Mol Oncol 2021
3

Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
Huma Q Rana, Lindsay Kipnis, Kristin Hehir, Angel Cronin, Tim Jaung, Samantha M Stokes, Fatemeh Fekrmandi, Donna Vatnick, Ursula A Matulonis, Judy E Garber,[...]. Gynecol Oncol 2021
1

Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers.
Renee Cowan, Silvana Pedra Nobre, Nisha Pradhan, Maya Yasukawa, Qin C Zhou, Alexia Iasonos, Robert A Soslow, Angela G Arnold, Magan Trottier, Amanda Catchings,[...]. Gynecol Oncol 2021
0

Current Approaches to Germline Cancer Genetic Testing.
Elena M Stoffel, John M Carethers. Annu Rev Med 2020
3

Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention.
Natalie E Griffin, Tommy R Buchanan, Stephanie H Smith, Andrea A Leon, Melissa F Meyer, Jingxia Liu, Rachel G Tabak, Katherine C Fuh, Premal H Thaker, Matthew A Powell,[...]. Gynecol Oncol 2020
6

Predictors of genetic testing uptake in newly diagnosed breast cancer patients.
Mary K Ladd, Beth N Peshkin, Claudine Isaacs, Gillian Hooker, Shawna Willey, Heiddis Valdimarsdottir, Tiffani DeMarco, Suzanne O'Neill, Savannah Binion, Marc D Schwartz. J Surg Oncol 2020
0

Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing.
Susan Randall Armel, Alexandra Volenik, Rochelle Demsky, Janet Malcolmson, Manjula Maganti, Jeanna McCuaig. Gynecol Oncol 2020
2

Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors.
Elizabeth K Lee, Ursula A Matulonis. Expert Opin Emerg Drugs 2020
1